LLY vs. NVO: Which Weight-Loss Drug Stock is a Stronger Play Now?Zacks Investment Research • 04/08/25
Eli Lilly And Novo Nordisk Could Face Policy Shifts As FDA Oversight, Tariff Risks MountBenzinga • 04/07/25
NVO & LLY Shares Down on Exclusion of Obesity Drugs From MedicareZacks Investment Research • 04/07/25
Eli Lilly, Novo Stocks Dive After Medicare Excludes Weight-Loss DrugsInvestors Business Daily • 04/04/25
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and ZepboundCNBC • 04/04/25
1 Ideal Buy From 23 "Safer" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)Seeking Alpha • 04/04/25
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocksCNBC • 04/01/25
Eli Lilly (LLY) Rises But Trails Market: What Investors Should KnowZacks Investment Research • 03/31/25
Eli Lilly Reverses Its Recent Upswing On Broader Market Woes. Is It A Sell?Investors Business Daily • 03/31/25